Skip to content
Recall Observatory FDA recall evidence

Drug product

Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3 Corporate Dr Lake Zurich, IL 60047-8930. NDC 63323-614-01

D-1327-2015

July 28, 2015

Class III

Product summary

Firm
Fresenius Kabi USA, LLC
Event
Event 71827
Status
Terminated
Classification
Class III
Quantity
93,000 vials
Official record key
drug-enforcement:D-1327-2015

Official wording

Reason: Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)

Code information: Lot #: 6110593, Exp 11/2016

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)